From: Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo
Altered gene | Gene name | Function | Fold change |
---|---|---|---|
CDC25A | Cell division cycle 25A | Cell cycle arrest. Allows time for DNA repair. | −2.79 |
CHEK2 | Checkpoint kinase 2 | Cell cycle check-point regulator and tumor suppressor | −2.24 |
E2F1 | E2F transcription factor 1 | Cell cycle control. Mediator of P53 - dependant apoptosis. | +2.27 |
TNFRSF25 (DR3) | TNF receptor superfamily; member 25 | Increases apoptosis. Anti-metastatic. | +3.4 |
ERBB2 | V-ERB-B2 avian erythroblastic leukemia viral oncogene homolog 2 | Oncogene. Mutations associated with lung cancer. | −2.16 |
ITGA1 | Integrin alpha-1 | Involved in cell-cell adhesion. | −2.11 |
ITGB3 | Integrin beta-3 | Cell adhesion and cell surface mediated signalling. Involvedin platelet aggregation. | +6.96 |
FGFR-2 | Fibroblast Growth factor R2 | Angiogenic receptor. Inhibition blocks small cell lung cancer growth in-vitro and in-vivo. | −8.27 |
IFNB-1 | Interferon B1 | Anti-tumor effects. | −2.07 |
MMP-9 | Matrix metalloproteinase-9 | Invasion of tumour cells through basement membrane. Implicated in lung metastasis of breast tumours. | +2.08 |
PLAU | Urinary plasminogen activator | Converts plasminogen to plasmin. Stimulates cell migration. | +2.04 |